344
Views
0
CrossRef citations to date
0
Altmetric
Case Report

An adult case of human parvovirus B19 infection developed ACPA-positive rheumatoid arthritis

, , , , , , , , & show all
Pages 1-4 | Received 09 Mar 2018, Accepted 05 Jun 2018, Published online: 10 Sep 2018

References

  • Seishima M, Shibuya Y, Watanabe K, et al. Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient. Mod Rheumatol. 2010;20:617–620.
  • Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–1108.
  • Arleevskaya MI, Gabdoulkhakova AG, Filina YV, et al. A transient peak of infections during onset of rheumatoid arthritis: a 10-year prospective cohort study. BMJ Open. 2014;4:e005254.
  • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219.
  • Okada Y, Kim K, Han B, et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet. 2014;23:6916–6926.
  • Anderson MJ, Kidd IM, Morgan-Capner P. Human parvovirus and rubella-like illness. Lancet 1985;326:663.
  • Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000;59:672–683.
  • Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53:459–475.
  • Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol. 2000;12:289–294.
  • Sasaki T. Autoimmune disease and human Parvovirus B19 infection. J Jpn Soc Int Med 1999;88:2499–2506.
  • White DG, Woolf AD, Mortimer PP, et al. Human parvovirus arthropathy. Lancet 1985;325:1:419–21.
  • Reid DM, Reid TMS, Brown T, et al. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1985;325:422–424.
  • Kerr JR, Cartron JP, Curran MD, et al. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol. 1995;34:809–813.
  • Nikkari S, Roivainen A, Hannonen P, et al. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis. 1995;54:597–600.
  • Peterlana D, Puccetti A, Beri R, et al. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J Rheumatol. 2003;30:1907–1910.
  • Caliskan R, Masatlioglu S, Aslan M, et al. The relationship between arthritis and human parvovirus B19 infection. Rheumatol Int. 2005;26:7–11.
  • Chen YS, Chou PH, Li SN, et al. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J Rheumatol. 2006;33:887–891.
  • Kozireva SV, Zestkova JV, Mikazane HJ, et al. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J Rheumatol 2008;35:1265–1270.
  • Tzang BS, Tsai CC, Tsay GJ, et al. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis. Clin Chim Acta. 2009;405:76–82.
  • Saal JG, Steidle M, Einsele H, et al. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int. 1992;12:147–151.
  • Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA. 1998;95:8227–8232.
  • Kakurina N, Kadisa A, Lejnieks A, et al. Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19. Medicina 2015;51:18–24.
  • Murai C, Munakata Y, Takahashi Y, et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis. 1999;58:130.
  • Sherina N, Hreggvidsdottir H, Bengtsson C, et al. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology. Arthritis Res Ther. 2017;19:219.
  • Gendi NS, Gibson K, Wordsworth BP. Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak. Ann Rheum Dis. 1996;55:63–65.
  • Cohen BJ, Buckley MM, Clewley JP, et al. Human parvovirus infection in an early rheumatoid and inflammatory arthritis. Ann Rheum Dis. 1986;45:832–838.
  • Moffatt S, Tanaka N, Tada K, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996;70:8485–8491.
  • Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380–386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.